Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus

被引:7
|
作者
Awadallah, Samir M. [1 ]
Saleh, Suleiman A. [1 ]
Abu Shaqra, Qasem M. [2 ]
Hilow, Hisham [3 ]
机构
[1] Hashemite Univ, Dept Med Lab Sci, Zarqa 13133, Jordan
[2] Diagnost Med Labs, Zarqa 13111, Jordan
[3] Univ Jordan, Dept Math, Amman 11942, Jordan
关键词
Cystatin C; Microalbuminuria; Diabetes; Haptoglobin;
D O I
10.1016/j.jdiacomp.2007.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recent studies have suggested an inheritable influence of haptoglobin phenotypes on the development of microalbuminuria in diabetic patients. In this study, we aimed to investigate whether microalbuminuria and serum levels of Cystatin C (Cys C) were correlated with haptoglobin phenotypes in patients with Type 2 diabetes mellitus. Methods: Fasting blood samples and first morning urine specimens were collected from 216 patients with type 2 diabetes (mean age 60.8 +/- 6.8) and from 108 healthy controls (mean age 59.3 +/- 6.5 years). Serum was used for the determination of Cys C, creatinine, and haptoglobin (Hp) phenotypes, while urine specimens were used for the determination of microalbuminuria. Microalbuminuria was expressed as albumin (mg)/creatinine (g) ratio [ACR (mg/g)], and patients were divided into three groups according to the values of ACR: normoalbuminuria ( <30), microalbuminuria (30-300) and macroalbuminuria ( > 300). Results: Irrespective of Hp phenotypes, Cys C, but not creatinine, was significantly higher in patients than that in controls. According to haptoglobin phenotypes, however, the levels of Cys C, duration of diabetes, and age, were significantly higher in patients with Hp1-1 phenotype than that in patients with the other phenotypes. Moreover, micro- and/or macroalbuminuria were present in all diabetic patients, with no significant difference in frequency of occurrence among the three Hp phenotypes. Multiple linear regression revealed that duration of diabetes and age of patient were significant predictors of Cys C (P < .0001), whereas creatinine associated with age only (P = .016). Logistic regression analysis showed that duration of diabetes [P <= .0001; odds ratio (OR) = 1.678, 95% CI = 1.43-1.97], and age (P = .0004; OR = 0.847, 95% CI = 0.77-0.93), significantly associated with micro- and/or macroalbuminuria. Hp phenotypes however, were not associated with any marker of kidney function. Conclusion: Findings from this study demonstrate no association between Hp phenotypes and markers of diabetic nephropathy. Markers of diabetic nephropathy however, are greatly influenced by duration of diabetes and age of patients. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:384 / 388
页数:5
相关论文
共 50 条
  • [21] Association of inflammatory cytokines with type 2 diabetes mellitus and diabetic nephropathy: a bidirectional Mendelian randomization study
    Song, Siyuan
    Ni, Jing
    Sun, Yuqing
    Pu, Qiang
    Zhang, Li
    Yan, Qianhua
    Yu, Jiangyi
    FRONTIERS IN MEDICINE, 2024, 11
  • [22] PREVALENCE OF RISK FACTORS OF DIABETIC NEPHROPATHY AND THEIR ASSOCIATION WITH ESTIMATED GFR IN PATIENTS OF TYPE 2 DIABETES MELLITUS
    Ali, Azmat
    Khan, Areeba
    Butt, Abdur Rahman
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2023, 21 (01): : 31 - 36
  • [23] Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy
    Chou, Su-Tze
    Tseng, Shih-Ting
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2017, 21 (02) : 283 - 292
  • [24] Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy
    Su-Tze Chou
    Shih-Ting Tseng
    Clinical and Experimental Nephrology, 2017, 21 : 283 - 292
  • [25] Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
    Moosaie, Fatemeh
    Rabizadeh, Soghra
    Fallahzadeh, Aida
    Sheikhy, Ali
    Meysamie, Alipasha
    Firouzabadi, Fatemeh Dehghani
    Nakhjavani, Manouchehr
    Esteghamati, Alireza
    DIABETES THERAPY, 2022, 13 (05) : 1023 - 1036
  • [26] Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
    Fatemeh Moosaie
    Soghra Rabizadeh
    Aida Fallahzadeh
    Ali Sheikhy
    Alipasha Meysamie
    Fatemeh Dehghani Firouzabadi
    Manouchehr Nakhjavani
    Alireza Esteghamati
    Diabetes Therapy, 2022, 13 : 1023 - 1036
  • [27] Inflammatory Markers as Predictors of Diabetic Nephropathy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Leucuta, Daniel-Corneliu
    Fumeaux, Pauline Aurelia
    Almasan, Oana
    Popa, Stefan Lucian
    Ismaiel, Abdulrahman
    MEDICINA-LITHUANIA, 2025, 61 (02):
  • [28] Diabetic nephropathy in patients with type 1 diabetes mellitus
    Russell, Troy A.
    NEPHROLOGY NURSING JOURNAL, 2006, 33 (01) : 15 - 28
  • [29] Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus
    Neamat-Allah, M
    Feeney, SA
    Savage, DA
    Maxwell, AP
    Hanson, RL
    Knowler, WC
    El Nahas, AM
    Plater, ME
    Shaw, J
    Boulton, AJM
    Duff, GW
    Cox, A
    DIABETIC MEDICINE, 2001, 18 (11) : 906 - 914
  • [30] Pre-clinical markers for diagnosis of diabetic nephropathy in patients with type 1 diabetes mellitus
    Lebedeva, N. O.
    Vikulova, O. K.
    DIABETES MELLITUS, 2012, 15 (02): : 38 - 45